Log In
Print
BCIQ
Print
Print this Print this
 

dasabuvir (ABT-333)

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionNon-nucleoside HCV NS5B polymerase inhibitor
Molecular Target HCV NS5B polymerase
Mechanism of ActionNon-nucleoside polymerase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat HCV genotype 1 infection
Regulatory Designation

U.S. - Fast Track (Treat HCV genotype 1 infection);
EU - Standard Review (Treat HCV genotype 1 infection)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today